肝脏脑病变复发的多组基因:对THEMATIC试验的分析
Jasmohan S Bajaj1, Andrew Fagan1, Richard K Sterling1
1Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and Richmond VA Medical Center, Richmond, Virginia, USA.
JHEP reports : innovation in hepatology
|January 8, 2026
概括
便微生物种移植 (FMT) 减少了肝脏脑病变 (HE) 的复发. 独特的肠道微生物组和代谢概况,包括短链脂肪酸和GABA,预测标准治疗患者的HE复发.
科学领域:
- 胃肠病学和肝病学
- 微生物组研究 微生物组研究
- 代谢学 代谢学 代谢学
背景情况:
- 肝脏脑病变 (HE) 的复发是肝硬化患者的一个重大问题.
- 便微生物群移植 (FMT) 在减少HE复发方面表现有前途.
- 对于HE复发的多原子预测因素的理解仍然不完全.
研究的目的:
- 为了确定肝脏脑病变 (HE) 在接受FMT治疗的患者中复发的多组预测因子.
- 分析肠道微生物组组成,代谢概况和HE复发之间的关联.
主要方法:
- 对 THEMATIC 随机对照试验数据的二次分析.
- 收集和分析便转基因组学,血清和尿液代谢学以及炎症性细胞因子.
- 利用路径,随机森林和潜在因子分析来识别复发预测因素.
主要成果:
- 高血压的复发与短链脂肪酸 (SCFA) 生产者的数量较少,GABA 生产类型的数量较高有关.
- 在患有复发的患者中观察到明显的尿和血清代谢概况,包括较低的SCFA和二次胆酸.
- 升高的IL-6水平和特定的微生物种群与增加的HE复发风险有关.
结论:
- HE复发与特定的肠道微生物和代谢特征有关,独立于FMT分配.
- 在SCFA生产,GABA代谢,胆酸概况和炎症的变化与HE复发有关.
- 供体微生物种植可能起到防止HE复发的保护作用.
相关概念视频
Therapeutic Drug Monitoring: Affecting Factors
196
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
196
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
179
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
179
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
249
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
249
Hepatic Drug Excretion: Influencing Factors
518
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
518
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
227
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
227


